Ethos Financial Group, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Ethos Financial Group, LLC

  • $528 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.28 - $1.16 $82,320 - $341,040
294,000 Added 1633.33%
312,000 $104,000
Q1 2024

May 08, 2024
BUY
$1.06 - $1.67 $19,080 - $30,060
18,000 New
18,000 $21,000
Q3 2023

Nov 13, 2023
SELL
$1.61 - $2.54 $198,672 - $313,433
-123,399 Reduced 66.59%
61,900 $112,000
Q1 2023

Apr 20, 2023
SELL
$1.2 - $2.19 $360 - $657
-300 Reduced 0.16%
185,299 $246,000
Q4 2022

Feb 09, 2023
BUY
$1.63 - $3.52 $302,526 - $653,308
185,599 New
185,599 $314 Million

Others Institutions Holding DNA

# of Institutions
41
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email